Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$209,279
-$34,820 QoQ
Shares Held
8,691
-0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,422
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Certified Advisory Corp holds $12,736,081 across 8 Drug Manufacturers - General names. PFE ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,212 | $4,117,361 | |
| 2 | LLY |
ELI LILLY & Co
|
3,249 | $3,896,948 | |
| 3 | ABBV |
AbbVie Inc.
|
7,683 | $1,933,350 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,732 | $850,520 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,383 | $820,215 | |
| 6 | AMGN |
Amgen Inc
|
1,762 | $638,055 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,692 | $270,353 | |
| 8 | PFE |
Pfizer Inc
This page
|
8,691 | $209,279 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,279 | 8,691 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $244,099 | 8,693 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $376,214 | 15,109 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $395,857 | 15,536 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $750,155 | 30,947 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,739,134 | 68,632 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,887,821 | 71,158 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,339,827 | 80,851 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,317,863 | 82,840 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,262,374 | 81,527 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,867,693 | 64,873 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,122,414 | 63,986 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,305,668 | 62,859 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,661,179 | 65,225 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $3,315,483 | 64,705 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $2,844,268 | 64,997 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,401,762 | 64,882 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,341,287 | 64,541 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,871,672 | 65,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,810,530 | 65,346 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,513,170 | 64,177 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,127,569 | 58,724 | Shares | Defined | 2021-05-10 | |
| 2020-06-30 | $1,802,686 | 55,128 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $1,619,691 | 49,623 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||